Eli Lilly is reducing the price of the highest doses of its popular drug Zepbound for folks who aren't using insurance.

Eli Lilly is unleashing self-pay discounts across the entirety of its obesity portfolio with new price cuts for higher doses ...

INDIANAPOLIS, Ind. - Eli Lilly and Company, a major pharmaceutical company, announced on Monday that its weight-loss drug, ...

Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access ...

The Indiana-based drugmaker’s much-publicized announcement was welcomed ... LLY applied the price cut only to 2.5 mg and 5.0 mg doses of Zepbound available on its direct-to-consumer platform ...

27, 2024 – The maker of the weight loss drug Zepbound is offering the drug at a reduced price for people willing ... week supply in prefilled pens. The announcement described the vials the ...

Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound ... The move to only cut the prices of the lowest doses, she added ...

On Tuesday, Eli Lilly announced that it would start selling low doses of its weight-loss drug Zepbound in vials, too — at a far lower price than ... Lilly’s announcement also presents a ...

Eli Lilly (NYSE:LLY) shares edged around 0.7% lower Tuesday as the company announced a price cut for its obesity drug Zepbound ... They believe the announcement also "likely further bolsters ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...